Invacare Holdings Corp
IVCDelisted Feb 16, 2023- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0000742112
Invacare Holdings Corp was delisted on Feb 16, 2023; its insiders filed their last Form 4 on Oct 31, 2024; 66 institutions reported holding it in 13F filings for Q4 2022, worth $7.88M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 11:30 AM ET
Revenue flow, FY2022
Where the revenue went in FY2022, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2022: $101.1M (13.6% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 1, 2023 | Mar 9, 2022 | Feb 10, 2021 | Feb 10, 2020 | Feb 13, 2019 |
| Revenue | $741.7M | $872.5M | $850.7M | $928.0M | $972.3M |
| Cost of revenue | $566.3M | $633.4M | $605.4M | $665.9M | $704.7M |
| Gross profit | $175.4M | $239.1M | $245.3M | $262.1M | $267.7M |
| Research and development | $3.49M | $8.66M | $12.3M | $15.8M | $17.4M |
| Selling, general and administrative | $226.8M | $232.2M | $236.4M | $260.1M | $281.9M |
| Operating income | -$80.5M | -$24.2M | $11.3M | -$10.4M | -$18.3M |
| Interest expense | $28.5M | $24.3M | $28.5M | $29.1M | $28.3M |
| Income tax | $3.07M | $6.45M | $3.84M | $9.30M | $9.82M |
| Net income | -$101.1M | -$45.6M | -$28.3M | -$53.3M | -$43.9M |
| EPS, basic | $-2.77 | $-1.31 | $-0.83 | $-1.59 | $-1.33 |
| EPS, diluted | $-2.77 | $-1.31 | $-0.83 | $-1.59 | $-1.33 |
| Weighted shares, basic | 36.5M | 34.9M | 34.3M | 33.6M | 33.1M |
| Weighted shares, diluted | 36.6M | 35.3M | 34.4M | 33.6M | 33.5M |
| Margins and growth | |||||
| Gross margin | 23.6% | 27.4% | 28.8% | 28.2% | 27.5% |
| Operating margin | -10.8% | -2.8% | 1.3% | -1.1% | -1.9% |
| Net margin | -13.6% | -5.2% | -3.3% | -5.7% | -4.5% |
| Revenue growth, year over year | −15.0% | +2.6% | −8.3% | −4.6% | +0.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 1, 2023 | Mar 9, 2022 | Feb 10, 2021 | Feb 10, 2020 | Feb 13, 2019 |
| Cash and equivalents | $58.8M | $83.7M | $105.3M | $80.1M | $116.9M |
| Accounts receivable | $88.0M | $117.1M | $108.6M | $116.7M | $119.7M |
| Inventory | $112.6M | $144.3M | $115.5M | $120.5M | $128.1M |
| Total current assets | $299.3M | $385.4M | $374.5M | $355.9M | $397.4M |
| Property, plant and equipment | $51.5M | $60.9M | $56.2M | $46.6M | $74.3M |
| Goodwill | $326.3M | $355.9M | $402.5M | $373.4M | $381.3M |
| Intangible assets | $21.7M | $26.4M | $27.8M | $26.4M | $26.5M |
| Total assets | $771.0M | $909.5M | $946.0M | $852.1M | $885.9M |
| Accounts payable | $104.6M | $130.0M | $85.4M | $88.0M | $92.5M |
| Short-term debt | $154.0K | $3.11M | $5.61M | $58.0K | $2.11M |
| Total current liabilities | $220.1M | $247.3M | $230.4M | $218.7M | $198.2M |
| Long-term debt | $354.1M | $305.0M | $239.4M | $219.5M | $253.5M |
| Shareholders' equity | $81.1M | $218.5M | $333.8M | $308.5M | $359.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 1, 2023 | Mar 9, 2022 | Feb 10, 2021 | Feb 10, 2020 | Feb 13, 2019 |
| Operating cash flow | -$55.3M | -$14.3M | $21.9M | $2.74M | – |
| Capital expenditures | $3.78M | $17.7M | $22.3M | $10.9M | $9.82M |
| Free cash flow | -$59.0M | -$32.0M | -$387.0K | -$8.13M | – |
| Depreciation and amortization | $15.5M | $16.8M | $14.3M | $15.6M | $15.6M |
| Stock-based compensation | $2.08M | $4.32M | $8.64M | $11.1M | $5.28M |
| Dividends paid | $0 | $0 | $414.0K | $1.65M | $1.63M |
| Share buybacks | $151.0K | $1.75M | $1.71M | $894.0K | $2.43M |
| Investing cash flow | -$4.32M | -$17.8M | -$9.55M | -$11.6M | -$6.36M |
| Financing cash flow | $38.3M | $12.9M | $6.26M | -$27.9M | -$2.92M |
| Net change in cash | -$25.0M | -$21.6M | $25.2M | -$36.8M | -$59.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.3% | 0.5% | 1.0% | 1.2% | 0.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| May 12, 2023 | 10.0M | – | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.